Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2017

View Archived Issues

FDA grants alirocumab orphan status for homozygous familial hypercholesterolemia

Apatinib mesylate receives U.S. orphan designation for treating gastric cancer

Burosumab granted FDA orphan drug status for tumor-induced osteomalacia syndrome

Sirnaomics' cotsiranib receives U.S. orphan status for primary sclerosing cholangitis

Porton Biopharma and NanoBio to advance intranasal anthrax vaccine

Leap Therapeutics to collaborate with Merck for evaluation of Keytruda in combination with DKN-01

First patient enrolled in a clinical trial evaluating treatment for mycetoma in Sudan

Daiichi Sankyo describes promising candidate for urinary tract infections, DS-86760016

Anti-KIR3DL2 monoclonal antibody IPH-4102 receives U.S. orphan designation

FDA names mirikizumab an orphan drug for the treatment of pediatric ulcerative colitis

Merck & Co. presents phase Ib results for rVSVdeltaG-ZEBOV-GP Ebola virus vaccine

Athera Biotechnologies' PC-mAb named U.S. orphan drug as company completes multiple-dosing study

GSK presents results from phase III study of revaccination with Shingrix

Preclinical data support entry of GyrB inhibitor DS-2969b into phase I development

EMA accepts Novartis' MAA filing for erenumab

Phase III cardiovascular risk reduction study of ACZ-885 meets primary endpoint

Identification of human MDA5 deficiency as a novel inborn error of innate and/or intrinsic immunity

Janssen enters agreement to use Adaptive Biotechnologies' assay in daratumumab studies

Sphingosine-1-phosphate is a potential marker of cystic fibrosis genotypes and presentation

GlaxoSmithKline describes novel hSTING modulators

CSIR identifies new CDK2/cyclin A and CDK9/cyclin-T1 inhibitors

Merck & Co. patents novel beta-secretase 1/2 inhibitors

Infuseon and OncoSynergy partner to test OS-2966 with Cleveland Multiport Catheter in glioblastoma

FDA gives orphan drug designation to pamrevlumab for pancreatic cancer

Kadimastem receives IRB approval for phase I/IIa trial of AstroRx in ALS

Novel mutation in INS gene tied to hereditary diabetes

DiAPREV-IT trial: first data for Alum-GAD for prevention of type 1 diabetes

FDA grants orphan drug designation to ibutamoren mesilate for growth hormone deficiency

EMA validates Veyvondi MAA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...